CytRx plans five Phase 2 clinical trials with oncology drug candidates

[News]

CytRx Corporation, a biopharmaceutical company specializing in oncology, today reported financial results for the twelve months ended December 31, 2009, and affirmed its 2010 milestones of commencing up to five Phase 2 clinical trials with its oncology drug candidates.

More... (http://www.news-medical.net/news/20100315/CytRx-plans-five-Phase-2-clinical-trials-with-oncology-drug-candidates.aspx)